<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02303925</url>
  </required_header>
  <id_info>
    <org_study_id>2013-41</org_study_id>
    <nct_id>NCT02303925</nct_id>
  </id_info>
  <brief_title>Feasibility of Superior Rectal Artery Embolization for the Treatment of Hemorrhoidal Disease</brief_title>
  <acronym>EMBORRHOID</acronym>
  <official_title>Feasibility of Superior Rectal Artery Embolization for the Treatment of Hemorrhoidal Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      With an estimated prevalence between 4 and 35%, the hemorrhoidal disease is the most frequent&#xD;
      proctologic disease. Its symptoms are mainly rectorrhagia, externalization of the&#xD;
      hemorrhoidal cushions (muco-hemorrhoidal prolapse), and/or pain and pruritus. Its acute&#xD;
      complications (external and/or internal thromboses) are unpredictable.&#xD;
&#xD;
      Surgical treatment concerns approximately 10% of patients with diagnosed hemorrhoidal&#xD;
      pathologies. The elective ligature of the arteria haemorrhoidalis under trans-anal Doppler&#xD;
      scanning was developed in order to reduce the postoperative morbidity of hemorrhoidal&#xD;
      surgery. This technique consists in a ligation of the superior rectal artery under Doppler&#xD;
      control in order to decrease the blood flow within the hemorrhoids and therefore to reduce&#xD;
      them. It is effective in the treatment of internal hemorrhoidal pathology without prolapse&#xD;
      (grade II). The complications rate is low and estimated between 2 and 12% : rectorrhagia&#xD;
      (4.3%), thrombosed hemorrhoids (1,8%), fissure (0,8%), acute urine retention (0,7%).&#xD;
&#xD;
      With the major advances in interventional radiology such ligation could be performed by an&#xD;
      endovascular coil embolization. Until now no direct study exists on the subject but several&#xD;
      case reports show the feasibility of an embolization of the superior rectal arteries for&#xD;
      rectorrhagia of various etiologies such as the hemorrhoidal disease.&#xD;
&#xD;
      Endovascular access should increase the selectivity of the embolization compared to the&#xD;
      Doppler scanning technique. Indeed the arteriography makes it possible to scan all branches&#xD;
      of the superior rectal artery and therefore to occlude permanently the branches that feed the&#xD;
      hemorrhoidal plexuses. Moreover the endovascular embolization technique should avoid the main&#xD;
      complications of the trans-anal access technique.&#xD;
&#xD;
      The primary objective of this study is : the assessment of the efficacy of endovascular coil&#xD;
      embolization of the superior rectal arteries in the management of the symptoms of the&#xD;
      hemorrhoidal disease grade II and III. The secondary objective is : the assessment of&#xD;
      postoperative complications.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 14, 2014</start_date>
  <completion_date type="Actual">June 30, 2018</completion_date>
  <primary_completion_date type="Actual">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Decrease of the felt pain</measure>
    <time_frame>26 MONTHS</time_frame>
    <description>It will be expected a decrease of the felt pain at least of 2 points measured by visual analog scale for patients treated by coil embolization</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reaaparition or obstinacy of the hemorroidal symptoms</measure>
    <time_frame>26 months</time_frame>
    <description>Reaaparition or obstinacy of the symptoms will be assess by clinical exam at 1,3,6 and 12 months</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Hemorrhoidal Disease</condition>
  <arm_group>
    <arm_group_label>coils</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NESTER COILS</intervention_name>
    <arm_group_label>coils</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Suffering from a symptomatic hemorrhoidal disease stage II or III (history of prior&#xD;
             medical treatment or instrumental do not prohibit the inclusion in the study)&#xD;
&#xD;
          -  Patient agreeing to participate in the study and who signed an informed consent&#xD;
&#xD;
          -  Patient willing to lend to post-operative monitoring for a year&#xD;
&#xD;
          -  Patient assured social&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diseases and colorectal proctologic / History proctologic&#xD;
&#xD;
          -  Acute Complication hemorrhoidal disease course (thrombosis)&#xD;
&#xD;
          -  History of proctology surgery for hemorrhoidal disease&#xD;
&#xD;
          -  Anal stenosis congenital or acquired&#xD;
&#xD;
          -  Chronic anal fissure, anal suppuration associated&#xD;
&#xD;
          -  Chronic Inflammatory Bowel Disease&#xD;
&#xD;
          -  History of colorectal cancer&#xD;
&#xD;
          -  History of rectal resection and / or sigmoid&#xD;
&#xD;
          -  Rectal prolapse&#xD;
&#xD;
          -  Comorbidities&#xD;
&#xD;
          -  Portal hypertension&#xD;
&#xD;
          -  Severe atherosclerotic pathology (significant stenosis in aorto-iliac-femoral artery&#xD;
             or branches for visceral).&#xD;
&#xD;
          -  General Affection responsible for a disorder of hemostasis objective (hemophilia, von&#xD;
             Willebrand disease thrombocytopenia) and anticoagulants.&#xD;
&#xD;
          -  Psychiatric disorder making it impossible informed of and / or postoperative care&#xD;
&#xD;
          -  Neurological disease directly or indirectly involving the rectosphinct√©rienne motor&#xD;
             (multiple sclerosis, spinal cord injury or nerve root, polyneuropathy).&#xD;
&#xD;
          -  Patients whose condition appears too insecure or taking steroids or immunosuppressive&#xD;
             leading to an unacceptable surgical risk.&#xD;
&#xD;
          -  Background&#xD;
&#xD;
          -  Pregnancy declared (the existence of effective contraception will be checked for women&#xD;
             of childbearing age)&#xD;
&#xD;
          -  Major Trust&#xD;
&#xD;
          -  Patients who do not speak French, refusing or unfit for monitoring proposed in the&#xD;
             study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle DESALBRES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <overall_official>
    <last_name>vincent vidal</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique Hopitaux De Marseille</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assistance Publique Hopitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <study_first_submitted>November 19, 2014</study_first_submitted>
  <study_first_submitted_qc>November 25, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 1, 2014</study_first_posted>
  <last_update_submitted>July 25, 2018</last_update_submitted>
  <last_update_submitted_qc>July 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

